KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Intangibles (2016 - 2025)

Globus Medical's Intangibles history spans 15 years, with the latest figure at $745.1 million for Q4 2025.

  • For Q4 2025, Intangibles fell 6.3% year-over-year to $745.1 million; the TTM value through Dec 2025 reached $745.1 million, down 6.3%, while the annual FY2025 figure was $745.1 million, 6.3% down from the prior year.
  • Intangibles reached $745.1 million in Q4 2025 per GMED's latest filing, down from $773.9 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.3 billion in Q3 2023 to a low of $1.8 million in Q1 2024.
  • Average Intangibles over 5 years is $380.7 million, with a median of $74.6 million recorded in 2021.
  • Peak YoY movement for Intangibles: soared 8705.74% in 2023, then tumbled 96.96% in 2024.
  • A 5-year view of Intangibles shows it stood at $68.7 million in 2021, then crashed by 84.71% to $10.5 million in 2022, then skyrocketed by 8705.74% to $924.6 million in 2023, then dropped by 14.0% to $795.1 million in 2024, then dropped by 6.3% to $745.1 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Intangibles are $745.1 million (Q4 2025), $773.9 million (Q3 2025), and $796.4 million (Q2 2025).